… SARS-CoV-2. And particularly, we introduced the protein structures of SARS-CoV-2 and
structure-based therapeutics development … limitations and perspectives of SARS-CoV-2 research…

… SARS-CoV-2 proteins can … of SARS-CoV-2 from the whole viral particle to the individual
viral proteins and discuss their functions as well as their potential as targets for therapeutic …

… The SARS-CoV spike (S) protein is composed of two subunits; the S1 subunit … SARS-CoV.
In this Review, we highlight recent advances in the development of vaccines and therapeutics …

… -2 virus belongs to the genus Betacoronavirus, like MERS-CoV and SARS-CoV, all of which
… basis of the SARS-CoV-2 infection and evolution, develop effective therapeutics, antiviral …

… The role of the S protein in binding with host receptors makes it a perfect target for vaccine
and antiviral therapeutic development. Previous studies on SARS-CoV and MESR-CoV have …

… of the SARS-CoV-2 E protein, and discuss its role in the viral life cycle and pathogenesis
process as well as the development of … structural motif for anti-SARS CoV-2 agent development. …

… towards novel therapeutic options for both SARS-CoV and MERS-CoV could be of great
help to identify potential treatments for SARS-CoV-2. Among them, the development of broad-…

… a practical therapeutic strategy for … developing vaccines and therapeutics against SARS-CoV-2.
This review highlights the anti–SARS-CoV-2 drug targets and therapeutic development …

… and environment and anti-CoV therapeutic strategies; including vaccines and … of SARS-CoV-2
infection with the hope that this integrative analysis could help develop novel therapeutic …

… Many organizations use the published genomes of the virus to develop possible vaccines
against SARS-CoV-2. As of August 2020, there are 231 vaccine candidates in the development…